2C-T-25

Last updated

2C-T-25
2CT25 structure.png
Clinical data
Other names4-Isobutylthio-2,5-dimethoxyphenethylamine; 4-iBuS-2,5-DMPEA
Routes of
administration 		Oral [1]
Drug class Serotonin receptor modulator; Serotonin 5-HT2A receptor agonist
ATC code
  • None
Identifiers
  • 2-[2,5-dimethoxy-4-(2-methylpropylsulfanyl)phenyl]ethanamine
PubChem CID
ChemSpider
Chemical and physical data
Formula C14H23NO2S
Molar mass 269.40 g·mol−1
3D model (JSmol)
  • CC(C)CSC1=C(C=C(C(=C1)OC)CCN)OC
  • InChI=1S/C14H23NO2S/c1-10(2)9-18-14-8-12(16-3)11(5-6-15)7-13(14)17-4/h7-8,10H,5-6,9,15H2,1-4H3
  • Key:OEPKQBQEDYEXMC-UHFFFAOYSA-N

2C-T-25, also known as 4-isobutylthio-2,5-dimethoxyphenethylamine, is a serotonin receptor modulator of the phenethylamine and 2C families. [1] [2] [3] [4] It shows affinity for serotonin receptors and other targets and acts as a potency partial agonist of the serotonin 5-HT2A and 5-HT2B receptors. [4] The dose of 2C-T-25 in humans is unknown. [5] Daniel Trachsel reported that 2C-T-25 was inactive at doses of up to 30 mg orally. [1] The drug was first described in the scientific literature by Trachsel in 2003 and was subsequently described further by Trachsel and colleagues in 2013 and 2018. [1] [2] [3] [4] It is a controlled substance in Canada under phenethylamine blanket-ban language. [6]

Contents

See also

References

  1. 1 2 3 4 Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. p. 788. ISBN   978-3-03788-700-4. OCLC   858805226. Archived from the original on 21 August 2025.
  2. 1 2 Shulgin A, Manning T, Daley P (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds . Vol. 1. Berkeley: Transform Press. ISBN   978-0-9630096-3-0.
  3. 1 2 Trachsel D (2003). "Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur–Aktivitätsbeziehungen. Mitteilung 2: 4-Thio-substituierte [2-(2,5-Dimethoxyphenyl)ethyl]amine (=2,5-Dimethoxybenzolethanamine)" [Synthesis of Novel (Phenylalkyl)amines for the Investigation of Structure–Activity Relationships. Part 2). 4-Thio-Substituted [2-(2,5-Dimethoxyphenyl)ethyl]amines (=2,5-Dimethoxybenzeneethanamines)]. Helvetica Chimica Acta. 86 (7): 2610–2619. doi:10.1002/hlca.200390210. ISSN   0018-019X.
  4. 1 2 3 Luethi D, Trachsel D, Hoener MC, Liechti ME (May 2018). "Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)". Neuropharmacology. 134 (Pt A): 141–148. doi:10.1016/j.neuropharm.2017.07.012. PMID   28720478.
  5. ↑ Luethi D, Liechti ME (October 2018). "Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics". The International Journal of Neuropsychopharmacology. 21 (10): 926–931. doi:10.1093/ijnp/pyy047. PMC   6165951 . PMID   29850881.
  6. ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.